CD40 抗体
Our Local Distributor
北京 101111
Quick Overview for CD40 抗体 (ABIN7670020)
抗原
See all CD40 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- Purified Anti-Human CD40 Antibody[3A8]
-
亚型
- IgG2b, kappa
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
浓度
- ≥ 1 mg/mL
-
缓冲液
- Phosphate buffered solution, pH 7.2, containing 0.05 % proclin 300.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- avoid freeze / thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles.
-
有效期
- 12 months
-
-
- CD40
-
别名
- CD40
-
背景
- CDW,B-cell surface antigen CD,Tumor necrosis factor receptor superfamily member,TNFRSF,CD40,Bp50,CDW40,TNFRSF5,p50,Tumor necrosis factor receptor superfamily member 5,B-cell surface antigen CD40,CD40L receptor, TNFRSF5,AI326936,B cell associated molecule CD40,B cell surface antigen CD40,B cell-associated molecule,CD 40,CD40 (protein),CD40 antigen,CD40 antigen (TNF receptor superfamily member 5),CD40 Molecule,CD40 protein,CD40 type II isoform,GP39,HIGM1,IGM,IMD3,isoform CRA_a,member 5,MGC9013,Nerve growth factor receptor related B lymphocyte activation molecule,OTTHUMP00000031699,OTTHUMP00000031700,TBAM,T-BAM,TNF receptor superfamily member 5,TNR5,TRAP,Tumor necrosis factor receptor superfamily,Tumor necrosis factor receptor superfamily member 5 precursor,CD40 is a type I transmembrane glycoprotein belonging to the TNF receptor superfamily. The mature hCD40 consists of a 172 amino acid (aa) extracellular domain, a 22 aa transmembrane region and a 62 aa cytoplasmic domain . Human and mouse CD40 share 62 % aa identity. CD40 is expressed in B cells, follicular dendritic cells, dendritic cells, activated monocytes, macrophages, endothelial cells, vascular smooth muscle cells, and several tumor cell lines.
-
UniProt
- P25942
-
途径
- NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
抗原
-